8 months ago
Ruby QC Exits Akums Drugs
Ruby QC Investment Holdings Pte, which is linked to Quadria Capital, sold all of its shares in Akums Drugs & Pharmaceuticals to ICICI Prudential Mutual Fund.
They sold 72.78 lakh shares, which is 4.62% of the company, for ₹311.5 crore.
The shares were sold at an average price of ₹428 each.
After the sale, the stock price of Akums Drugs closed at ₹443.70, which is higher than the sale price.
Akums Drugs had its initial public offering (IPO) last year at a price between ₹646 and ₹679.
After reaching a high of ₹1,066.65 right after the IPO, the stock has been going down.
Ruby QC Investment Holdings Pte sold 72.78 lakh shares (4.62% equity) in Akums Drugs & Pharmaceuticals to ICICI Prudential Mutual Fund for ₹311.5 crore.
The shares were sold at an average price of ₹428 each.
The stock of Akums Drugs closed at ₹443.70 on the BSE, 3.8% higher than the previous day.
Akums Drugs had its IPO in August 2024 with a price band of ₹646-679 and reached a high of ₹1,066.65 post-listing.
The stock has been on a downtrend since its listing high.
- Who
- Ruby QC Investment Holdings Pte and ICICI Prudential Mutual Fund
- What
- Sale of 72.78 lakh shares in Akums Drugs & Pharmaceuticals
- Where
- India
- When
- December 22, 2025
- Why
- To exit the investment in Akums Drugs & Pharmaceuticals
Key facts
- Company
- Akums Drugs & Pharmaceuticals
- Shares Sold
- 72.78 lakh
- Percentage of Equity
- 4.62%
- Sale Price
- ₹311.5 crore
- Average Share Price
- ₹428
- Buyer
- ICICI Prudential Mutual Fund
- Stock Price at Close
- ₹443.70
- Listing Price Range
- ₹646-679
- Highest Stock Price
- ₹1,066.65
- Investor
- Ruby QC Investment Holdings Pte
